Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 888 of 6351
-
New drug combo aims to shrink Hard-to-Treat neuroendocrine tumors
Disease control Recruiting nowBackground: A neuroendocrine tumor is a rare type of tumor. It comes from body cells called neuroendocrine cells. Sometimes, these tumors develop in the gastrointestinal tract and pancreas. Researchers want to find out if a combination of drugs can shrink these tumors. Objectiv…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could online coaching for parents boost autistic Children's social skills?
Symptom relief CompletedThis preliminary single-arm pre-post interventional study was designed to evaluate the acceptability and preliminary clinical outcomes of an 8-week online group-based parent-mediated intervention (OYNA) for parents of young autistic children. Mothers and fathers independently com…
Sponsor: Herguner Therapy Private Clinic • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Can ketamine stop teen suicidal urges in days?
Symptom relief CompletedThis project aims to examine the signal of efficacy of ketamine, a rapidly acting medication shown to decrease suicidality in adults in as short as hours or days, as opposed to weeks. The study design is a double-blind, randomized, active-control trial of adolescents (ages 13-18…
Phase 3 • Sponsor: University of Texas Southwestern Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Could a simple breath test spot hidden diseases early?
Diagnosis CompletedThis is a prospective, multicentric, non-treatment study to build and validate a portable, non-invasive smart breath analyzer that can screen underlying health issues using exhaled breath. The study will be conducted with healthy participants and participants with known cases of …
Sponsor: Respyr • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
Could viruses be the new weapon against tough lung infections in cystic fibrosis?
Disease control CompletedThis is a phase 1b/2 study of a single dose of intravenous (IV) bacteriophage in males and non-pregnant females, at least 18 years old, diagnosed with Cystic Fibrosis (CF). This clinical trial is designed to assess the safety and microbiological activity of bacteriophage product …
Phase 1/2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
AI eyes colon polyps: can it spot the dangerous ones?
Diagnosis CompletedThe goal of this substudy is to investigate the accuracy of a computer-aided polyp characterization (CADx) system. The main question\[s\] it aims to answer are: • How high is the specificity of the AI system when characterizing colorectal polyps Participants will receive a stan…
Sponsor: Ismail Gögenur • Aim: Diagnosis
Last updated Aug 29, 2026 00:00 UTC
-
New drug cocktail aims to beat back leukemia that won't quit
Disease control Recruiting nowThis study aims to investigate the efficacy and safety of cladribine, venetoclax combined with cytarabine and venetoclax (CAV regimen) for relapsed/refractory (R/R) Philadelphia Chromosome-negative (Ph-) B-cell acute lymphoblastic leukemia (B-ALL).
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New Three-Drug cocktail aims to tackle tough leukemia
Disease control Recruiting nowThis study aims to investigate the efficacy and safety of cladribine, combined with low-dose cytarabine and venetoclax (CAV regimen) for relapsed/refractory acute myeloid leukemia (R/R AML).
Phase 2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Early therapy may rewire motor development in premature infants
Disease control OngoingStudy Aims Pilot study: Due to the large recruitment goal and length of the project, the study team/PIs will evaluate the first cohort of 6-10 participants to refine study procedures and study-related materials. If no major modifications are made to the protocol as a result of t…
Sponsor: Shirley Ryan AbilityLab • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can allergy and glaucoma drugs regrow hair when delivered by microneedling?
Disease control CompletedThis study planned to measure the effectiveness and safety of microneedling aided administration of cetirizine 1% versus latanoprost 0.01% in alopecia areata.
Sponsor: Tanta University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can brain stimulation restore a steady voice?
Disease control Recruiting nowDeep Brain Stimulation (DBS) is a neurosurgical procedure used to treat tremors, and dystonia. This study will enroll people who have a form of focal dystonia that affects their vocal cords called Adductor Laryngeal dystonia (ADLD). Participants will undergo Deep Brain Stimulatio…
Sponsor: Indiana University • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
AI boosts colonoscopy accuracy in massive VA trial
Diagnosis CompletedThe goal of this cluster randomized study is to determine if artificial intelligence systems used during colonoscopy can improve the detection of precancerous polyps in the colon. The primary question it aims to answer is whether computer-assisted detection devices improve the pr…
Sponsor: VA Puget Sound Health Care System • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
Could less blood pressure medicine save more lives in heart shock?
Disease control Recruiting nowRationale: Pump failure due to acute myocardial infarction (AMI) can lead to cardiogenic shock (CS): a state of low blood flow to end-organs with subsequent multi-organ failure that is associated with high mortality rated. The first line pharmacologic treatment strategy in CS is …
Phase 4 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New combo attack on rectal cancer: chemo plus targeted surgery shows promise
Disease control CompletedThe goal of this clinical trial is to compare in newly diagnosed patients with resectable rectal cancer with lateral lymph node metastasis. This study aims to * further verify the safety and efficacy of FOLFOXIRI three-drug regimen * Using multiple omics techniques to identify a…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New inpatient therapy aims to stop suicide in veterans
Disease control By invitation onlyPsychiatric hospitalization is a critical opportunity to provide treatment to reduce the risk of suicide and lay the groundwork for functional recovery. In fact, the period following psychiatric hospitalization presents the greatest risk of death by suicide for Veterans. Despite …
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a blood test spot teen suicide risk?
Knowledge-focused Recruiting nowThis study is dedicated to help identify biomarkers for depression and suicide. The purpose of the study is to better understand these links to improve medical and psychiatric care in the future. This research is also to test the effects of standard treatment of depression on imp…
Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
New shot cuts migraine days by half in chinese trial
Disease control CompletedPrimary Objective: To demonstrate the efficacy of fremanezumab administered as monthly and quarterly subcutaneous (sc) injections to adult Chinese participants with migraine. Secondary Objectives: * To further demonstrate the efficacy of fremanezumab administered as monthly an…
Phase 3 • Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New combo aims to unleash immune system against tough ovarian cancer
Disease control OngoingEpithelial ovarian cancer (OC) is the most lethal gynecologic cancer: nearly 22,000 women are diagnosed with OC in the US annually and 63% are expected to die from their disease. The 5-year overall survival rate is unacceptably low at 20-30%, with \> 50% of patients experiencing …
Phase 1/2 • Sponsor: Alexander B Olawaiye, MD • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug combo aims to shrink tough breast cancer tumors
Disease control OngoingThis research is being done to evaluate the safety and effectiveness of Onvansertib in combination with Paclitaxel in triple-negative breast cancer (TNBC) that has spread to other parts of the body. The names of the study interventions involved in this study are: * Onvansertib …
Phase 1/2 • Sponsor: Antonio Giordano, MD • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New drug shows promise for inflammatory bowel disease in Mid-Stage trial
Disease control CompletedThe primary objective is to characterize the efficacy TEV-48574 in adult participants with IBD (moderate to severe Ulcerative Colitis (UC) or Crohn's Disease (CD)) as assessed by induction of clinical remission (UC) and endoscopic response (CD) at week 14. Secondary objectives: …
Phase 2 • Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC